Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration. [electronic resource]
- Neuroendocrinology 2020
- 155-157 p. digital
Publication Type: Letter; Comment
1423-0194
10.1159/000503392 doi
Capecitabine Duration of Therapy Fluorouracil Humans Neuroendocrine Tumors Temozolomide